Regulation of Skeletal Growth
Regulation of Skeletal Growth
批准号:
6108021
负责人:
Jeffrey Baron
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
autosomal dominant trait bone development bone metabolism cartilage child (0-11) clinical research developmental genetics endocrinology fibroblast growth factor gene mutation glucocorticoids hormone receptor hormone regulation /control mechanism human subject hypercalciuria hypoparathyroidism kidney cell messenger RNA neuroendocrine system normal ossification organ culture osteocytes parathyroid gland receptor expression somatotropin
中文摘要
点击翻译按钮获取中文摘要
英文摘要
We identified mutations in the Ca2+-sensing
receptor gene in patients with hypoparathyroidism. We have
demonstrated that these mutations can either cosegregate with the
disease in families with an autosomal dominant inheritance pattern
or can arise de novo in patients with sporadic disease. When
expressed in cultured cells, these mutations caused activation of the
receptor by increasing the sensitivity to calcium and increasing
maximal signal transduction capacity.We have also studied the
regulation of mammalian longitudinal bone growth. We showed
that fasting rapidly decreases longitudinal bone growth and growth
plate width in vivo. This growth inhibition does not appear to be
mediated by the local, growth plate insulin-like growth factor-I
(IGF-I) system which was up-regulated. Instead it was associated
with down-regulation of the systemic IGF-I system.Growth plate
cartilage and the adjacent bone exhibit spatial polarity. By
manipulating the spatial relationships within the growth plate, we
have shown that the polarity of growth plate cartilage is determined
by intrinsic factors. The cartilage polarity then determines the
polarity of the adjacent bone and, consequently, the functional
polarity of longitudinal bone growth. Other studies explore the role
of fibroblast growth factor-2, retinoids, C-type natiuretic peptide,
and cGMP in the regulation of cell proliferation and differentiation
in the growth plate.Treatment trials using growth hormone or IGF-I
for the treatment of extreme short stature are underway. We are
beginning an additional clinical trial using alendronate, an inhibitor
of bone resorption, to treat pediatric osteoporosis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Genetic Diagnosis of Childhood Growth Disorders
-
批准号:9260116
-
项目类别:
-
资助金额:$16.87万
-
财政年份:2017
-
负责人:Jeffrey Baron
-
依托单位:
Regulation Of Childhood Growth
-
批准号:7734701
-
项目类别:
-
资助金额:$109.9万
-
财政年份:--
-
负责人:Jeffrey Baron
-
依托单位:
Regulation Of Skeletal Growth
-
批准号:7594144
-
项目类别:
-
资助金额:$363.68万
-
财政年份:--
-
负责人:Jeffrey Baron
-
依托单位:
海外基金